Innate Immune Modulators in the Lung
Monday, March 3, 2014: 4:45 PM-6:00 PM
Convention Center, Upper Level, Room 7AB
1.25 CME/ 1.50 CE
Harald E. Renz , MD
Learning Objectives:
  1. Recognize the capacity of surfactant phospholipids in suppression of lung inflammation due to aeroallergen, bacterial infection and viral infection
  2. Describe how surfactant protein-A and D suppress lung inflammation
  3. Discuss the therapeutic potential of TLR blockade in the treatment of lung diseases
4:45 PM
Anionic Pulmonary Surfactant Phospholipids Act as a Regulator of Inflammation and Viral Infection in the Lung
Dennis R. Voelker, PhD
5:00 PM
Surfactant Protein-A and D in Airway Inflammation
Angela Haczku, MD PhD FAAAAI
5:15 PM
Antagonism of Toll-Like Receptor Activation in Lung Disease
Anthony A. Horner, MD FAAAAI
5:30 PM
Question & Answer
See more of: Q & A Workshop